Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Head and Neck Cancer

Free Subscription 25.03.2019 1 Ann Otol Rhinol Laryngol 1 Ann Surg 1 Ann Thorac Surg 6 Anticancer Res 1 BMC Cancer 1 Br J Oral Maxillofac Surg 2 Cancer Res 3 Dis Esophagus 4 Head Neck 1 Histopathology 2 Int J Cancer 7 Int J Radiat Oncol Biol Phys 1 J Clin Endocrinol Metab 4 Laryngoscope 2 PLoS One 1 Proc Natl Acad Sci U S A 1 Surgery 3 Thyroid

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Otol Rhinol Laryngol

1. ABU-GHANEM S, Sung CK, Junlapan A, Kearney A, et al
   Endoscopic Management of Postradiation Dysphagia in Head and Neck Cancer Patients: A Systematic Review.
   Ann Otol Rhinol Laryngol. 2019 Mar 21:3489419837565.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg

2. ADAM MA, Thomas S, Youngwirth L, Hyslop T, et al
   Reply to: "Surgeon Volume Threshold for Total Thyroidectomy".
   Ann Surg. 2018;267:e78-e79.
   PubMed     Text format    
   
   

   
   Ann Thorac Surg

3. CHENG YF, Wang BY, Chen HS
   Will patients with resectable esophageal cancer be spared esophagectomy? (Reply).
   Ann Thorac Surg. 2019 Mar 16. pii: S0003-4975(19)30359.
   PubMed     Text format    
   
   

   
   Anticancer Res

4. HAGIO K, Furuya S, Nakamura J, Maruyama S, et al
   High miR-3687 Expression Affects Migratory and Invasive Ability of Oesophageal Carcinoma.
   Anticancer Res. 2019;39:557-565.
   PubMed     Text format     Abstract available
   
   
5. ISRAEL Y, Rachmiel A, Gourevich K, Nagler R, et al
   Survival Probabilities Related to Histology, Grade and Stage in Patients With Salivary Gland Tumors.
   Anticancer Res. 2019;39:641-647.
   PubMed     Text format     Abstract available
   
   
6. ELTWERI AM, Thomas AL, Chung WY, Morgan B, et al
   The Effect of Supplementary Omegaven(R) on the Clinical Outcome of Patients With Advanced Esophagogastric Adenocarcinoma Receiving Palliative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy: A Phase II clinical trial.
   Anticancer Res. 2019;39:853-861.
   PubMed     Text format     Abstract available
   
   
7. LI MU, Gu S, Mao R, Ning Y, et al
   County Median Family Income Is an Independent Prognostic Factor for Stage IV Anaplastic Thyroid Cancer.
   Anticancer Res. 2019;39:949-956.
   PubMed     Text format     Abstract available
   
   
8. ASAKA S, Shimakawa T, Yamaguchi K, Katsube T, et al
   Postoperative Pneumonia After Esophagectomy and Systemic Inflammatory Response Syndrome.
   Anticancer Res. 2019;39:979-985.
   PubMed     Text format     Abstract available
   
   
9. SUZUKI H, Tamaki T, Nishio M, Terada H, et al
   Uptake of (18)F-Fluorodeoxyglucose in Major Salivary Gland Cancer Predicts Survival Adjusting for Pathological Stage.
   Anticancer Res. 2019;39:1043-1049.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

10. WANG Y, Jiang Z, Xu C, Wang H, et al
    Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
    BMC Cancer. 2019;19:240.
    PubMed     Text format     Abstract available
    
    

    
    Br J Oral Maxillofac Surg

11. MILNE S, Parmar J, Ong TK
    Adult Comorbidity Evaluation-27 as a predictor of postoperative complications, two-year mortality, duration of hospital stay, and readmission within 30 days in patients with squamous cell carcinoma of the head and neck.
    Br J Oral Maxillofac Surg. 2019 Mar 16. pii: S0266-4356(19)30006.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

12. WANG Z, Feng X, Molinolo AA, Martin D, et al
    4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.
    Cancer Res. 2019 Mar 20. pii: 0008-5472.CAN-18-1220.
    PubMed     Text format     Abstract available
    
    
13. BHATIA S, Oweida A, Lennon S, Darragh LB, et al
    Inhibition of EphB4-ephrin-B2 signaling reprograms the tumor immune microenvironment in head and neck cancers.
    Cancer Res. 2019 Mar 20. pii: 0008-5472.CAN-18-3257.
    PubMed     Text format     Abstract available
    
    

    
    Dis Esophagus

14. NELSON DB, Mitchell KG, Weston BR, Betancourt S, et al
    Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer?
    Dis Esophagus. 2019 Mar 19. pii: 5393319. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
15. QIN J, Zhu HD, Guo JH, Ni CF, et al
    Factors associated with overall survival and relief of dysphagia in advanced esophageal cancer patients after 125I seed-loaded stent placement: a multicenter retrospective analysis.
    Dis Esophagus. 2019 Mar 19. pii: 5393322. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
16. OGUMA J, Ozawa S, Kazuno A, Yamamoto M, et al
    Prognostic impact of lymphovascular invasion in lymph node-negative superficial esophageal squamous cell carcinoma.
    Dis Esophagus. 2019 Mar 18. pii: 5382620. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Head Neck

17. SCHILLING C, Stoeckli SJ, Vigili MG, de Bree R, et al
    Surgical consensus guidelines on sentinel node biopsy (SNB) in patients with oral cancer.
    Head Neck. 2019 Mar 21. doi: 10.1002/hed.25739.
    PubMed     Text format     Abstract available
    
    
18. KIM H, Shin JH, Hahn SY, Oh YL, et al
    Prediction of follicular thyroid carcinoma associated with distant metastasis in the preoperative and postoperative model.
    Head Neck. 2019 Mar 19. doi: 10.1002/hed.25721.
    PubMed     Text format     Abstract available
    
    
19. HENRY M, Fuehrmann F, Hier M, Zeitouni A, et al
    Contextual and historical factors for increased levels of anxiety and depression in patients with head and neck cancer: A prospective longitudinal study.
    Head Neck. 2019 Mar 19. doi: 10.1002/hed.25725.
    PubMed     Text format     Abstract available
    
    
20. MEANS C, Clayburgh DR, Maloney L, Sauer D, et al
    Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status.
    Head Neck. 2019 Mar 21. doi: 10.1002/hed.25740.
    PubMed     Text format     Abstract available
    
    

    
    Histopathology

21. FENG J, Xie G, Zhan Y, Lu J, et al
    Elevated HSP90 associates with expression of HIF-1alpha and p-AKT and predicts the poor prognosis in the nasopharyngeal carcinoma.
    Histopathology. 2019 Mar 18. doi: 10.1111/his.13862.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

22. LIU X, Song M, Wang P, Zhao R, et al
    Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
    Int J Cancer. 2019 Mar 18. doi: 10.1002/ijc.32285.
    PubMed     Text format     Abstract available
    
    
23. ISLAMI F, Poustchi H, Pourshams A, Khoshnia M, et al
    A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma.
    Int J Cancer. 2019 Mar 20. doi: 10.1002/ijc.32220.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

24. GAN GN, Kimple RJ
    Genomics Reloaded: Rise of the Expression Profiles.
    Int J Radiat Oncol Biol Phys. 2018;101:1-3.
    PubMed     Text format    
    
    
25. SHER DJ, Timmerman RD, Nedzi L, Ding C, et al
    Phase I fractional dose escalation study of equipotent stereotactic radiotherapy regimens for early-stage glottic larynx cancer.
    Int J Radiat Oncol Biol Phys. 2019 Mar 14. pii: S0360-3016(19)30323.
    PubMed     Text format     Abstract available
    
    
26. ANDERSON CM, Sonis ST, Lee CM, Adkins D, et al
    Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2018;100:427-435.
    PubMed     Text format     Abstract available
    
    
27. BRODIN NP, Kabarriti R, Garg MK, Guha C, et al
    Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.
    Int J Radiat Oncol Biol Phys. 2018;100:391-407.
    PubMed     Text format     Abstract available
    
    
28. ZHENG B, Zhu X, Liu M, Yang Z, et al
    Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;100:418-426.
    PubMed     Text format     Abstract available
    
    
29. GEBHARDT BJ, Vargo JA, Ling D, Jones B, et al
    Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;101:195-200.
    PubMed     Text format     Abstract available
    
    
30. LUDMIR EB, Paulino AC, Grosshans DR, McAleer MF, et al
    Regional Nodal Control for Head and Neck Alveolar Rhabdomyosarcoma.
    Int J Radiat Oncol Biol Phys. 2018;101:169-176.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Endocrinol Metab

31. GIANNINI R, Moretti S, Ugolini C, Macerola E, et al
    Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: an ATC-like and a PDTC-like.
    J Clin Endocrinol Metab. 2019 Mar 18. pii: 5381919. doi: 10.1210/jc.2018-01167.
    PubMed     Text format     Abstract available
    
    

    
    Laryngoscope

32. PANTH N, Simpson MC, Sethi RKV, Varvares MA, et al
    Insurance status, stage of presentation, and survival among female patients with head and neck cancer.
    Laryngoscope. 2019 Mar 22. doi: 10.1002/lary.27929.
    PubMed     Text format     Abstract available
    
    
33. JIANG ST, Smith RV
    Is core needle biopsy safe and effective for the assessment of head and neck lesions?
    Laryngoscope. 2018;128:2669-2670.
    PubMed     Text format    
    
    
34. RIZVI ZH, Alonso JE, Kuan EC, St John MA, et al
    Treatment outcomes of patients with primary squamous cell carcinoma of the retromolar trigone.
    Laryngoscope. 2018;128:2740-2744.
    PubMed     Text format     Abstract available
    
    
35. WU CW, Dionigi G, Barczynski M, Chiang FY, et al
    International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic data.
    Laryngoscope. 2018;128 Suppl 3:S18-S27.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

36. HUNG YH, Liu SA, Wang CC, Wang CP, et al
    Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck.
    PLoS One. 2018;13:e0205365.
    PubMed     Text format     Abstract available
    
    
37. ABRAMOWITZ L, Lacau Saint Guily J, Moyal-Barracco M, Bergeron C, et al
    Epidemiological and economic burden of potentially HPV-related cancers in France.
    PLoS One. 2018;13:e0202564.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

38. SUN C, Li T, Song X, Huang L, et al
    Spatially resolved metabolomics to discover tumor-associated metabolic alterations.
    Proc Natl Acad Sci U S A. 2019;116:52-57.
    PubMed     Text format     Abstract available
    
    

    
    Surgery

39. SHAHA AR, Tuttle RM
    Risk of disease progression during active surveillance of papillary thyroid cancer.
    Surgery. 2017 Nov 6. pii: S0039-6060(17)30638-4. doi: 10.1016/j.surg.2017.
    PubMed     Text format     Abstract available
    
    

    
    Thyroid

40. MATRONE A, Latrofa F, Torregrossa L, Piaggi P, et al
    Changing trend of thyroglobulin antibodies in not 131I ablated differentiated thyroid cancer patients.
    Thyroid. 2018 Jun 2. doi: 10.1089/thy.2018.0080.
    PubMed     Text format     Abstract available
    
    
41. MOSS W, Finegersh A, Pang J, Califano JA, et al
    Needle biopsy of routine thyroid nodules should be performed using a capillary action technique with 24-27 gauge needles: a systematic review and meta-analysis.
    Thyroid. 2018 May 10. doi: 10.1089/thy.2017.0643.
    PubMed     Text format     Abstract available
    
    
42. CHO YY, Kang MJ, Kim SK, Jung J, et al
    Protective Effect of Metformin against Thyroid Cancer Development: a Population-based Study in Korea.
    Thyroid. 2018 May 29. doi: 10.1089/thy.2017.0550.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: